Cyanidin‐3‐ O ‐Glucoside Attenuates Articular Cartilage Damage in Experimental Osteoarthritis and Is Associated With Nrf2/HO‐1 Signaling
Cyanidin-3-O-glucoside (C3G) has antioxidant and anti-inflammatory activity, but its effects in experimental osteoarthritis (OA) remain unclear. We investigated C3G-associated responses in IL-1β-stimulated rat chondrocytes and in rats with monosodium iodoacetate (MIA)-induced OA. Matrix-based proteomic profiling was used to characterize treatment-associated protein-expression changes and to prioritize candidates for targeted experiments. In chondrocytes, C3G partially attenuated IL-1β-associated loss of viability and reduced inflammatory and oxidative-stress markers. C3G treatment was associated with increased NRF2 nuclear accumulation and increased HO-1 and NQO1 expression, whereas NRF2 knockdown attenuated these in vitro responses. In the MIA-induced OA model, C3G treatment was associated with lower OARSI scores, increased COL2A1 and ACAN expression, and reduced MMP13 and ADAMTS5 expression. These findings support the involvement of NRF2-associated signaling in the in vitro response to C3G, but do not establish the upstream mechanism of NRF2 regulation or NRF2 dependence in vivo.
Authors
- Yang Liu (ORCID: https://orcid.org/0000-0003-3831-7153)
- Zhenyang Yu (ORCID: https://orcid.org/0000-0003-1776-9230)
- Xin Guo
- Qingchao Ru
- Jianing Lu
- Yijun Lian
Institutions
- First Affiliated Hospital of Xinxiang Medical University (CN)
Publication Details
- Journal
- Journal of Biochemical and Molecular Toxicology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1002/jbt.71187
- Primary Topic
- Osteoarthritis Treatment and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00